Status:
RECRUITING
Impact of Hepatitis B Virus on Inflammatory Bowel Disease
Lead Sponsor:
Tanta University
Conditions:
Inflammatory Bowel Disease (IBD)
Hepatitis B Virus
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian pati...
Eligibility Criteria
Inclusion
- Male or female patients older than 18 years.
- Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.
Exclusion
- Patients aged \< 18 years
- Unwilling to participate in our study
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 10 2025
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT06881238
Start Date
December 1 2024
End Date
June 10 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University Hospitals
Tanta, Gharbyea, Egypt, 31516